The global veterinary vaccines market is witnessing steady growth due to the rising incidence of animal diseases, increasing livestock production, and growing awareness of preventive animal healthcare. Veterinary vaccines play a crucial role in protecting companion animals and livestock from infectious diseases, improving animal health outcomes, and supporting food safety across global supply chains.

According to industry estimates, the global veterinary vaccines market size is projected to reach US$ 13.67 billion by 2031 from US$ 9.13 billion in 2024, reflecting strong expansion across both developed and emerging markets. The market is anticipated to register a CAGR of 6.0% during 2025–2031, driven by increasing adoption of preventive veterinary care and advancements in vaccine technologies.

Market Drivers: Key Factors Accelerating Industry Growth

Rising Prevalence of Animal Diseases and Zoonotic Infections

One of the most significant drivers of the veterinary vaccines market is the increasing incidence of infectious diseases among animals. Outbreaks such as avian influenza, rabies, foot-and-mouth disease, and swine fever continue to impact livestock productivity and public health. This has led governments and veterinary organizations to implement large-scale immunization programs, significantly boosting vaccine demand.

Expanding Livestock Population and Global Food Demand

The growing global demand for animal-based protein is driving expansion in livestock farming. As poultry, cattle, and swine production increases, the need for disease prevention becomes more critical. Vaccination is a cost-effective method to reduce mortality, improve yield, and ensure food safety, making veterinary vaccines essential in modern animal husbandry systems.

Get Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00003539

Increasing Pet Ownership and Companion Animal Healthcare Awareness

Rising pet adoption rates, particularly in urban areas, have significantly contributed to the growth of the companion animal vaccine segment. Pet owners are increasingly investing in preventive healthcare, including routine vaccinations for dogs, cats, and horses. This shift toward responsible pet care is strengthening demand for advanced veterinary immunization products.

Technological Advancements in Vaccine Development

Innovations in biotechnology, including recombinant DNA technology, live attenuated vaccines, and mRNA-based platforms, are enhancing vaccine efficacy and safety. These advancements are enabling the development of more targeted and long-lasting immunization solutions, thereby improving adoption across veterinary healthcare systems.

Government Immunization Programs and Disease Control Initiatives

Many governments and international organizations are actively promoting animal vaccination programs to control zoonotic diseases and protect public health. Subsidized vaccination campaigns, regulatory support, and veterinary infrastructure development are further accelerating market growth globally.

Rising Investments in Veterinary Healthcare Infrastructure

Increasing investments in veterinary clinics, animal hospitals, and vaccine manufacturing facilities are strengthening global supply chains. Leading companies are expanding production capacities and investing in R&D to develop next-generation vaccines, improving accessibility and affordability in both developed and developing regions.

Market Segmentation Trends

The veterinary vaccines market is segmented by technology, animal type, route of administration, and end-user. Among these, live attenuated vaccines hold a significant share due to their strong immune response and long-lasting protection.

In terms of animal type, livestock vaccines dominate the market due to high demand for disease prevention in food-producing animals. However, the companion animal segment is expanding rapidly, supported by rising pet ownership trends and increasing veterinary visits.

Veterinary hospitals and clinics remain the primary end-users, while livestock farms are also a key contributor to market demand, especially in regions with large agricultural economies.

Top Players in the Global Veterinary Vaccines Market

• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Merck & Co. Inc. (Animal Health Division)
• Elanco Animal Health Incorporated
• Virbac
• Ceva Santé Animale
• Vetoquinol S.A.
• Bayer Animal Health (now part of Elanco portfolio)
• Hester Biosciences Limited
• Phibro Animal Health Corporation

These companies are focusing on innovation, strategic acquisitions, expansion of manufacturing facilities, and development of advanced vaccine platforms to strengthen their global market presence.

Future Outlook: Veterinary Vaccines Market by 2031

The future of the veterinary vaccines market is highly promising, supported by increasing awareness of animal health, rising zoonotic disease risks, and continuous advancements in vaccine technologies. The industry is expected to move toward more precision-based immunization strategies, including genetically engineered vaccines and thermostable formulations suitable for remote regions.

Emerging economies in Asia-Pacific and Latin America are expected to witness strong growth due to expanding livestock industries, improving veterinary infrastructure, and government-led disease eradication programs. Additionally, the integration of digital monitoring systems and data-driven animal health management will further enhance vaccination efficiency and compliance.

Overall, the veterinary vaccines market is set for consistent growth, driven by the convergence of biotechnology innovation, preventive healthcare adoption, and global food security priorities.

Frequently Asked Questions (FAQs)

1. What is the growth rate of the global veterinary vaccines market?

The global veterinary vaccines market is expected to grow at a CAGR of 6.0% during 2025–2031, driven by rising animal disease prevalence and increasing preventive healthcare adoption.

2. What is the projected market size of veterinary vaccines by 2031?

The market is projected to reach US$ 13.67 billion by 2031, increasing from US$ 9.13 billion in 2024.

3. What are the key drivers of the veterinary vaccines market?

Key drivers include rising livestock production, increasing pet ownership, growing animal disease outbreaks, technological advancements in vaccine development, and government immunization programs.

Top Trending Reports:

Pet Veterinary Drugs Market Drivers, Trends, and Forecasts by 2034

Farm Animal Drugs Market Key Players and Opportunities by 2028

Farm Animal Healthcare Market Statistics, Trends, Size, and Share by 2031

About Us

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us

The Insight Partners
Email: [email protected]
Phone: +1-646-491-9876
Website: www.theinsightpartners.com

Also Available in: Korean German Japanese French Chinese Italian Spanish